Furthermore, DLBCL patients were categorized into high and low expression groups regarding the median expression levels of BAFF and FCRL 1 and the median serum level of LDH, which showed the overall survival time. The gene discussed is TNFSF13B; the disease is diffuse large B-cell lymphoma.